JPRN-UMIN000010318已完成未知
Effects of transglucosidase on diabetes, cardiovascular risk factors, and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial - TG Effect on Diabete
agoya City University Graduate School of Medical Sciences0 个研究点目标入组 66 人开始时间: 2013年3月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who had a history of gut resection.
研究者
相似试验
招募中
不适用
Cardioprotective Effect of SGLT2-I in Diabetic Patients With AMI (SGLT2-I AMI PROTECT Study)Diabetes MellitusAcute Coronary SyndromeNCT05261867IRCCS Azienda Ospedaliero-Universitaria di Bologna800
已完成
不适用
Evaluation of the effects on blood glucose level: a randomized, double-blind, crossover trialHealthy Japanese adult peopleJPRN-UMIN000030701ORTHOMEDICO Inc.10
已完成
4 期
Study for the effect of blood glucose and metabolic risk factors by switching Sulfonylurea to SGLT2 inhibitor in patients with type 2 diabetes. -prospective observational studyType 2 diabetes mellitusJPRN-UMIN000016347Hokkaido University Hospital200
已完成
4 期
The Glucose Tolerance Test StudyAnti-inflammatory effect of insulin after Oral versus intravenous glucose in overweight individuals.Overweight/obesityMetabolic and Endocrine - Normal metabolism and endocrine development and functionACTRN12612000491864niverstiy of otago15
已完成
不适用
ong-term effects of voglibose on diabetic complication in Japanese patients with type 2 diabetes mellitus: a double-blind, randomized, placebo-controlled clinical trialType 2 diabetesJPRN-UMIN000001111Takeda Pharmaceutical Company Limited550